THERAPY WORKSHEET

Citation: Sulistyarini, Indahria. "Terapi relaksasi untuk menurunkan tekanan darah

dan meningkatkan kualitas hidup penderita hipertensi." Jurnal psikologi 40.1 (2013):
28-38.

Are the results of this single preventive or therapeutic trial valid?

Was the assignment of patients to Ya. Karena pada subjek penelitian

treatments randomised? diberikan perlakuan yang berbeda yaitu,
ada kelompok yang diberikan perlakuan
relaksasi dan yang tidak diberikan
relaksasi

Was the randomisation list concealed?
Tidak dijelaskan secara pasti didalam
jurnal. Tetapi pengambilan subjek untuk
tiap kelompok sejumlah 15orang dengan
kriteria pria/wanita berusia 35-75 tahun,
status perkawinan menikah, memiliki
tekanan darah sistolik (SBP)>130
mmHg dan tekanan darah diastolik
(DBP) > 80mmHg, telah menderita
hipertensi minimal enam bulan
terakhir, namun tidak mengalami
kerusakan organis dan berdomisili di
wilayah kerja Puskesmas X.

Was follow-up of patients sufficiently Ya. Karna terus dilakukan follow up

long and complete?
Were all patients analysed in the groups to
which they were randomised?
Were patients and clinicians kept “blind”
to treatment?
Were the groups treated equally, apart
from the experimental treatment?
Were the groups similar at the start of the
trial?
selama 3 kali pertemuan.
Ya. Karna kedua kelompok subjek
sama-sama dianalisis kualitas hidup dan
tekanan darahnya.
Ya.
Tidak. Karena di kelompok kontrol
tidak mendapat relaksasi.
Ya. Karna dalam jurnal ini disertakan
kriteria inklusi penelitian sehingga
keadaan kedua kelompok sama.

Are the valid results of this randomised trial important?

SAMPLE CALCULATIONS
Occurrence of diabetic Relative risk Absolute risk Number
neuropathy at 5 years among reduction reduction needed to
 insulin-dependent diabetics in (RRR) (ARR) treat (NNT)
the DCCT trial
Usual insulin Intensive insulin
regimen regimen CER – EER CER-EER 1/ARR
control event experimental CER
rate (CER) event rate (EER)
2.8% 9.6% - 2.8% 9.6% - 2.8% 1/6.8%
9.6% = 6.8% = 15 patients
= 71%
95% CI * 4.4% to 9.2% 11 to 23

* 95% confidence interval (CI) on an NNT = 1/(limits on the CI of its ARR) =

 CER  (1  CER )   EER  (1  EER )   0.96  0.904   0.028  0.972 
 1.96       1.96     2.4%
 # ofControlPts   # ofExperPts   730   711 

YOUR CALCULATIONS
Relative risk Absolute risk Number
reduction reduction needed to
(RRR) (ARR) treat (NNT)
CER EER CER – EER CER-EER 1/ARR
CER

95% CI 

Can you apply this valid, important evidence about therapy in caring for your
patient?
Do these results apply to your patient?
Is your patient so different from those in
the study that its results cannot apply?
Is the treatment feasible in your setting?
What are your patient’s potential benefits and harms from the therapy?
Method I: f Risk of the outcome in your patient,
relative to patients in the trial.
Expressed as a decimal: ______
NNT/f = ______ / ______ = ______
(NNT for patients like yours)
Method II: 1/(PEER x RRR) Your patient’s expected event rate if they
received the control treatment (PEER)
= ______
1/(PEERxRRR) = 1/________ = ______
(NNT for patients like yours)
Are your patient’s values and preferences satisfied by the regimen and its
consequences?
Do your patient and you have a clear
assessment of their values and
preferences?
Are they met by this regimen and its
consequences?

Additional notes: